Panax notoginseng saponins inhibits NLRP3 inflammasome-mediated pyroptosis by downregulating lncRNA-ANRIL in cardiorenal syndrome type 4

Cardiorenal syndrome type 4 (CRS4) is a complication of chronic kidney disease. Panax notoginseng saponins (PNS) have been confirmed to be efficient in cardiovascular diseases. Our study aimed to explore the ther...

Source: Chinese Medicine - May 8, 2023 Category: Complementary Medicine Authors: Ying Xu, Luxi Cao, Wenli Zou, Rizhen Yu and Wei Shen Tags: Research Source Type: research